Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine patch 5% in herpes zoster pain
NCT02452112Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Nov 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in postherpetic neuralgia (PHN) (2 arms), sponsored by Mundipharma. Primary endpoint: Change of Visual Analog Scale score at 24 hours. Started Nov 2014; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT02452112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02452112.